When does the Vraylar (cariprazine) patent expire?
Vraylar’s patent expiry depends on which specific patent or patent family you mean (there are multiple patents tied to the drug and its formulations). DrugPatentWatch.com tracks the relevant patent status for cariprazine (Vraylar) and can show the different “earliest” and “latest” expiry dates across patents.
For the most up-to-date expiry information, check DrugPatentWatch’s Vraylar patent listing here: https://www.drugpatentwatch.com/p/vraylar-patent/ [1]
Does Vraylar lose exclusivity before the last patent expires?
Yes—patent expiry and market exclusivity can differ. Even after certain patents expire, other patents (process, formulations, or additional claims) can keep generic or competing products off the market for longer. That’s why tracking the specific patent(s) listed for Vraylar matters.
DrugPatentWatch groups the underlying patents and shows their timelines, which is the most practical way to compare “earliest” versus “latest” dates. [1]
What should I check to get the exact date for my country?
Patent expiry is country-specific, and the available data can vary by jurisdiction. If you tell me the country (for example, US, EU, UK, Canada, or Australia), I can help you interpret the likely “patent expiry vs. exclusivity” timeline and what to look for on the patent tracker. [1]
Source
[1] https://www.drugpatentwatch.com/p/vraylar-patent/